Abeona Therapeutics Inc. (ABEO)
NASDAQ: ABEO · Real-Time Price · USD
4.840
-0.030 (-0.62%)
Mar 6, 2026, 1:21 PM EST - Market open
Abeona Therapeutics Employees
Abeona Therapeutics had 136 employees as of December 31, 2024. The number of employees increased by 52 or 61.90% compared to the previous year.
Employees
136
Change (1Y)
52
Growth (1Y)
61.90%
Revenue / Employee
$2,941
Profits / Employee
$605,515
Market Cap
262.29M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| AC Immune | 172 |
| Coherus Oncology | 158 |
| Prelude Therapeutics | 131 |
| Silence Therapeutics | 116 |
| Enlivex | 71 |
| Orchestra BioMed Holdings | 70 |
| Surrozen | 41 |
| Fennec Pharmaceuticals | 32 |
ABEO News
- 3 days ago - Abeona Therapeutics® Announces Date of Fourth Quarter / Full Year 2025 Financial Results and Participation in Upcoming 2026 Leerink Global Healthcare Conference - GlobeNewsWire
- 25 days ago - Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Abeona Therapeutics® Announces Appointment of Mohamad Tabrizi as Chief Business Officer - GlobeNewsWire
- 3 months ago - Abeona Therapeutics® Announces New Qualified Treatment Center for ZEVASKYN® in Texas - GlobeNewsWire
- 3 months ago - Abeona Therapeutics® Announces First Patient Treatment with ZEVASKYN® Gene Therapy - GlobeNewsWire
- 4 months ago - Abeona Therapeutics Q3 2025: Strong Financials And Zevaskyn Launch Ahead - Seeking Alpha
- 4 months ago - Abeona Therapeutics Inc. (ABEO) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Abeona Therapeutics® Reports Third Quarter 2025 Financial Results and Corporate Updates - GlobeNewsWire